AstraZeneca PLC Ordinary Shares (AZN)

Total Assets

$115.70B

Quarterly · Period ending: · USD

AZN logo

AZN Total Assets

Latest reported$115.70B
AZN Quarterly Total Assets ($7.42B → $115.70B)
High-resolution chart · PNG

AZN total assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Total Assets — Quarterly (USD)
Period endingTotal Assets (USD)
115,697,727,000
114,015,000,000
114,074,000,000
114,456,000,000
112,422,000,000
106,253,000,000
104,035,000,000
104,922,000,000
104,340,000,000
102,293,000,000
101,119,000,000
96,086,000,000
96,543,000,000
96,687,000,000
96,483,000,000
94,185,000,000
96,579,000,000
100,273,000,000
105,363,000,000
107,221,000,000
73,641,000,000
64,926,000,000
66,729,000,000
64,112,000,000
59,929,000,000
57,211,000,000
61,377,000,000
58,906,000,000
61,889,000,000
61,055,000,000
60,651,000,000
61,443,000,000
61,344,000,000
63,281,000,000
63,354,000,000
64,587,000,000
65,119,000,000
60,959,000,000
62,526,000,000
63,222,000,000
64,419,000,000
64,323,000,000
60,124,000,000
54,118,000,000
55,169,000,000
53,701,000,000
58,595,000,000
56,164,000,000
58,539,000,000
59,390,000,000
55,899,000,000
54,121,000,000
53,987,000,000
52,329,000,000
53,534,000,000
52,448,000,000
51,390,000,000
50,763,000,000
52,830,000,000
52,576,000,000
53,406,000,000
54,534,000,000
56,127,000,000
56,390,000,000
54,647,000,000
54,075,000,000
54,920,000,000
51,899,000,000
50,200,000,000
46,515,000,000
46,784,000,000
48,204,000,000
50,202,000,000
48,458,000,000
47,957,000,000
45,950,000,000
47,600,000,000
29,565,000,000
29,932,000,000
28,122,000,000
28,459,000,000
29,932,000,000
24,840,000,000
24,527,000,000
24,884,000,000
24,840,000,000
25,616,000,000
24,471,000,000
24,343,000,000
23,785,000,000
23,573,000,000
23,054,000,000
22,207,710,639
22,532,080,938
21,576,000,000
20,534,777,291
20,319,182,073
19,989,947,629
26,445,036,339
19,105,057,214
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.